Clinical Trials Logo

Communicable Diseases clinical trials

View clinical trials related to Communicable Diseases.

Filter by:

NCT ID: NCT01776021 Completed - Infection Clinical Trials

Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections

Start date: January 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effects of a cranberry juice beverage on rates of Urinary tract infection (UTI) recurrence in women with a history of UTI.

NCT ID: NCT01773824 Completed - Clinical trials for Urinary Tract Infections

Routine Prescription Feedback and Peer Comparison to Lower Antibiotic Prescriptions in Primary Care

Start date: October 2013
Phase: N/A
Study type: Interventional

To evaluate the effect of a continuous postal and web-based feedback and peer comparison system of individual antibiotic prescription rates on the prescription behaviour of primary care physicians in Switzerland.

NCT ID: NCT01772901 Completed - Pregnancy Clinical Trials

Brief Influenza Vaccine Education to Pregnant Women

Start date: October 2013
Phase: N/A
Study type: Interventional

The investigators will conduct a brief educational intervention to pregnant women who have not yet received the influenza vaccine in this pregnancy to improve the uptake of seasonal influenza vaccine.

NCT ID: NCT01771653 Completed - Clinical trials for Hepatitis C Infection

Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection

Start date: September 2011
Phase: N/A
Study type: Observational

The purpose of this observational study is to compare two approved treatment regimen(s) containing boceprevir and telaprevir, as part of standard of care for the treatment of hepatitis C.

NCT ID: NCT01769365 Completed - Clinical trials for Helicobacter Pylori Infection

Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection

Start date: July 2010
Phase: Phase 4
Study type: Interventional

To simultaneously compare the efficacies of 7-day triple, 10-day sequential and 7-day quadruple therapies for H. pylori infection in Taiwan. Consecutive H. pylori-infected patients were randomly assigned to a 7-day standard triple therapy (pantoprazole, clarithromycin, and amoxicillin for 7 days), a 10-day sequential therapy (pantoprazole and amoxicillin for 5 days, followed by pantoprazole, clarithromycin and metronidazole for a further 5 days) or a 7-day quadruple therapy (pantoprazole, clarithromycin, amoxicillin and metronidazole for 7 days). The end point is to evaluate the effectiveness of Helicobacter pylori eradication rates between three groups.

NCT ID: NCT01767116 Completed - Clinical trials for Chronic Hepatitis C Infection

A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection

PEARL-III
Start date: December 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and antiviral activity of ABT-450/ritonavir/ABT-267 (ABT-450/r/ABT-267; ABT-450 also known as paritaprevir; ABT-267 also known as ombitasvir) and ABT-333 (also known as dasabuvir) with and without ribavirin (RBV) in patients with chronic hepatitis C virus genotype 1b (HCV GT1b) infection without cirrhosis.

NCT ID: NCT01765920 Completed - Clinical trials for Acute Upper Respiratory Tract Infections

Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adults

Start date: December 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is: - to evaluate safety of the liquid dosage form of Ergoferon in the treatment of acute upper respiratory tract infections in adults; - to evaluate clinical efficacy of the liquid dosage form of Ergoferon in the treatment of acute upper respiratory tract infections in adults.

NCT ID: NCT01763008 Completed - Clinical trials for Urinary Tract Infection

A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections

Start date: November 2009
Phase: Phase 4
Study type: Observational

The purpose of this study is to assess the safety and effectiveness of doripenem treatment among Filipino patients with nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infection.

NCT ID: NCT01762904 Completed - Infectious Diseases Clinical Trials

Residual Effect of Chlorhexidine-alcohol Compared to Triclosan-alcohol

Start date: January 2013
Phase: Phase 3
Study type: Interventional

Currently there are few options for skin antisepsis, commercially antiseptic triclosan is mainly used. To have more options, this study is necessary, where investigators will determine the residual effect of 2% chlorhexidine in 70% isopropyl alcohol and 1% triclosan in 70% isopropyl alcohol and choose the one with the best characteristics for skin antisepsis.

NCT ID: NCT01761799 Completed - Influenza Clinical Trials

Protecting Pregnant Women From Infectious Diseases

Start date: December 2012
Phase: N/A
Study type: Interventional

The primary research aim of this project is to test the effectiveness of a comprehensive, evidence-based vaccine promotion package implemented in the obstetric setting on increasing the likelihood that a pregnant woman in Georgia will receive an influenza and/or pertussis vaccine.